Literature DB >> 19041274

Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.

Yulia Golub1, Daniela Berg, Donald B Calne, Ronald F Pfeiffer, Ryan J Uitti, A Jon Stoessl, Zbigniew K Wszolek, Matthew J Farrer, Jakob C Mueller, Thomas Gasser, Julia Fuchs.   

Abstract

Patients with Leucine-rich repeat kinase 2 (LRRK2) linked Parkinson's disease (PD) clinically present with typical idiopathic PD. However, LRRK2-linked PD displays a pleomorphic neuropathology and high variability in age at disease onset (AAO) which suggests that environmental and/or genetic factors other than the mutation itself influence the course of the disease. We investigated the modulation of AAO by genetic factors including the mutation-containing domain and PD associated polymorphisms in the gene coding alpha-synuclein (SNCA) and tau (MAPT) in 44 patients from 19 affected families. Using this limited number of available LRRK2 mutation carriers, we provide evidence that mutations in the kinase domain of Lrrk2 significantly decrease AAO compared to mutations in the ROC (Ras/GTPase of complex proteins) domain. Furthermore, polymorphic variations in MAPT show a significant association with AAO in individuals with LRRK2 mutations. Our results await replication in future studies with a larger number of LRRK2 mutation carriers, but indicate an association of mutation-affected protein domain and mutation-extrinsic genetic factors with AAO and suggest that these factors could contribute to explain the phenotypic heterogeneity observed in LRRK2-linked PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041274     DOI: 10.1016/j.parkreldis.2008.10.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  17 in total

1.  Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.

Authors:  Ziv Gan-Or; Anat Bar-Shira; Tanya Gurevich; Nir Giladi; Avi Orr-Urtreger
Journal:  Neurogenetics       Date:  2011-08-12       Impact factor: 2.660

2.  Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.

Authors:  Jeanne C Latourelle; Audrey E Hendricks; Nathan Pankratz; Jemma B Wilk; Cheryl Halter; William C Nichols; James F Gusella; Anita L Destefano; Richard H Myers; Tatiana Foroud
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

3.  The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.

Authors:  Ziv Gan-Or; Anat Bar-Shira; Anat Mirelman; Tanya Gurevich; Nir Giladi; Avi Orr-Urtreger
Journal:  J Mol Neurosci       Date:  2011-09-06       Impact factor: 3.444

Review 4.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

5.  Does rate of progression run in essential tremor families? Slower vs. faster progressors.

Authors:  Elan D Louis; Nora Hernandez; Iuliana Ionita-Laza; Ruth Ottman; Lorraine N Clark
Journal:  Parkinsonism Relat Disord       Date:  2012-10-31       Impact factor: 4.891

6.  The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease.

Authors:  Z Gan-Or; I Amshalom; A Bar-Shira; M Gana-Weisz; A Mirelman; K Marder; S Bressman; N Giladi; A Orr-Urtreger
Journal:  J Neurol       Date:  2015-08-02       Impact factor: 4.849

7.  No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease.

Authors:  Victoria Berge-Seidl; Lasse Pihlstrøm; Zbigniew K Wszolek; Owen A Ross; Mathias Toft
Journal:  Neurobiol Aging       Date:  2018-09-22       Impact factor: 4.673

8.  Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

Authors:  Albert A Davis; Kristin M Andruska; Bruno A Benitez; Brad A Racette; Joel S Perlmutter; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2015-09-30       Impact factor: 4.673

9.  Family-based association analysis of the MAPT gene in Parkinson disease.

Authors:  K S Wang; J E Mullersman; X F Liu
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

10.  Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.

Authors:  Mariet Allen; Fanggeng Zou; High Seng Chai; Curtis S Younkin; Richard Miles; Asha A Nair; Julia E Crook; V Shane Pankratz; Minerva M Carrasquillo; Christopher N Rowley; Thuy Nguyen; Li Ma; Kimberly G Malphrus; Gina Bisceglio; Alexandra I Ortolaza; Ryan Palusak; Sumit Middha; Sooraj Maharjan; Constantin Georgescu; Debra Schultz; Fariborz Rakhshan; Christopher P Kolbert; Jin Jen; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Ryan J Uitti; Zbigniew K Wszolek; Owen A Ross; Ronald C Petersen; Neill R Graff-Radford; Dennis W Dickson; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  Mol Neurodegener       Date:  2012-04-11       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.